The Magee Prize was established in 2018 as a global award designed to be a catalyst for transformational research in women’s health and reproductive biology. It funds a collaborative team whose research could improve lives around the world.
The award will support a 2-3 year research program on an innovative, transdisciplinary project in the fields of reproductive biology, early human development, or women’s health.
The project should be proposed jointly by two or more collaborating principal investigators (PIs): one international investigator located anywhere in the world and at least one Magee-Womens Research Institute (MWRI) investigator. Applications are encouraged in any relevant biological discipline, from basis or translational biology to clinical and health services research. Projects may be conceptual or methodological, involve new models or drugs, and ideally based on high-risk and high-reward strategies.
The three prize finalists will be invited to present their projects at the Magee-Womens Summit on May 26th, with summit attendees contributing via live vote to the final awardee.
Prize structure ($1 Million)
The first prize is comprised of a $972,000 total research award (which includes indirect costs at a maximum rate of 8%) and a $18,000 personal prize, shared across the co-PIs
In addition, the following personal prizes will include:
Second prize: $6,000, shared across the co-PIs
Third prize: $4,000, shared across the co-PIs
SUBMISSION TIMELINE
Letter of Intent: November 2, 2020
Abstracts due: January 4, 2021
Magee Prize finalists announced: April 30, 2021
Prize finalist research presentations: May 26, 2021 at The Magee-Womens Summit
Final selection: May 26, 2021 at The Magee-Womens Summit
Comments